Cargando…
A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB
Using the best available evidence and expert consensus, this document provides guidance for adverse effect monitoring in multidrug-resistant TB (MDR-TB). It includes recommendations for baseline tests, routine drug and toxicity monitoring guides as well as individual drug monographs for all drugs cu...
Autores principales: | Potter, J L, Capstick, T, Ricketts, W M, Whitehead, N, Kon, O M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345768/ https://www.ncbi.nlm.nih.gov/pubmed/24928813 http://dx.doi.org/10.1136/thoraxjnl-2014-205278 |
Ejemplares similares
-
TB REACTIVATION FOLLOWING COVID-19 INFECTION
por: COLBY, STEVEN, et al.
Publicado: (2022) -
TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015) -
TB AND COVID-19 COINFECTION: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022) -
ACTIVE TB AFTER THE USE OF TOCILIZUMAB FOR COVID-19 INFECTION
por: NOH, SUNGRYONG, et al.
Publicado: (2021) -
REACTIVATION MILIARY TB IN THE SETTING OF POSTINFECTIOUS COVID-19 LUNGS
por: ASHA, SHARMIN, et al.
Publicado: (2022)